About
Stratipath develops AI-based diagnostic software that uses deep learning to perform prognostic risk profiling of invasive breast cancer, enabling faster, cost-effective, and clinically validated precision diagnostics for improved cancer treatment decisions.
Explore Stratipath's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.